Texas Court Ruling Strikes Blow to Bristol-Myers in Plavix Venue Dispute
“`html Bristol-Myers Squibb Co. has encountered a significant setback in its legal maneuvers concerning the proper venue for litigation over its blood-thinning medication, Plavix. A Texas judge ruled against the pharmaceutical giant, determining that Texas is indeed a suitable jurisdiction for the ongoing litigation surrounding claims of misleading marketing practices related to the drug. This…